PERSONAL CHARACTERISTICS AND REPRODUCTIVE HISTORY

_

  = Use the method

_

  = Do not use the method

I

  = Initiation of the method

C

  = Continuation of the method

  = Use the method

NA

  = Not applicable

Condition

Combined oral contraceptives Monthly injectables Combined patch and combined vaginal ring Progestin-only pills Progestin-only injectables Implants Emergency contraceptive pills* Copper-bearing intrauterine device Levonorgestrel intrauterine device Female sterilization*

PERSONAL CHARACTERISTICS AND REPRODUCTIVE HISTORY

Pregnant

NA

NA

NA

NA

NA

NA

NA

4

4

D

Age

Menarche to

< 40 years

Menarche to

< 18 years

Menarche

to <20

years

Young

age

1

1

1

1

2

1

2

2

C

≥ 40 years

18 to 45 years

≥ 20 years

2

2

2

1

1

1

1

1

> 45 

1

2

1

Parity

Nulliparous (has not

given birth)

1

1

1

1

1

1

2

2

A

Parous (has given birth)

1

1

1

1

1

1

1

1

A

Breastfeeding

< 6 weeks postpartum

4

4

4

3a

3a

3a

1

b

b

*

≥ 6 weeks to < 6 months postpartum (primarily breastfeeding)

3

3

3

1

1

1

1

b

b

A

≥ 6 months postpartum

2

2

2

1

1

1

1

b

b

A

Postpartum

(not breastfeeding)

< 21 days

3

3

3

1

1

1

b

b

*

With other added VTE risk factors

3/4**

3/4**

3/4**

           

21–42 days

2

2

2

1

1

1

b

b

With other added VTE risk factors

2/3**

2/3**

2/3**

             

>42 days

1

1

1

1

1

1

1

1

A

Postabortion

First trimester

1

1

1

1

1

1

1

1

*

Second trimester

1

1

1

1

1

1

2

2

Immediate post-septic abortion

1

1

1

1

1

1

4

4

Past ectopic pregnancy

1

1

1

2

1

1

1

1

1

A

History of pelvic surgery

1

1

1

1

1

1

1

1

C*

Smoking

 

Age < 35 years

2

2

2

1

1

1

1

1

A

Age ≥ 35 years

<15 cigarettes/day

3

2

3

1

1

1

1

1

A

≥15 cigarettes/day

4

3

4

1

1

1

1

1

A

Obesity

≥ 30 kg/m² body mass index

2

2

2

1

1

1

1

1

C

Blood pressure measurement unavailable

NAc

NAc

NAc

NAc

NAc

NAc

NA

NA

NA

 

* See additional conditions relating to emergency contraceptive pills and female sterilization.

** Category depends on the number, severity, and combination of risk factors for VTE.

a In settings where pregnancy morbidity and mortality risks are high and this method is one of few widely available contraceptives, it may be made accessible to breastfeeding women immediately postpartum.

b Postpartum IUD use: For the copper-bearing IUD, insertion at 4 weeks, category 1; and puerperal sepsis, category 4.

From menarche to age <18 years, ≥30 kg/m2 body mass index is category 2 for DMPA, category 1 for NET-EN.

 c In settings where pregnancy morbidity and mortality risks are high and this method is one of few widely available contraceptives, women should not be denied access simply because their blood pressure cannot be measured.

Previous Chapter Previous Page Next Page Next Chapter